Vitamins and Dietary Supplements in Hungary

Publication Date	May 2009
Publisher	Euromonitor
Product Type	Report
Pages	43
ISBN Number	not applicable
Product Code	EUR00222

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Vitamins and Dietary Supplements in Hungary report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

vitamins, dietary supplements, tonics and bottled nutritive drinks, child-specific vitamins and dietary supplements

Data coverage:

market sizes (historic and forecasts), company shares and brand shares.

Why buy this report?

Get a detailed picture of the vitamins and dietary supplements industry;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Vitamins and Dietary Supplements in Hungary
Euromonitor International
May 2009
List of Contents and Tables
- Executive Summary
- Trend Towards Self-medication Drives Modest Market Development in 2008
- Chemists/pharmacies Continue To Dominate OTC Healthcare Distribution
- Competitive Landscape in Analgesics Shifts Following 2007 Switches
- Deregulation Leads To More Intense Competition in Chemists/pharmacies
- Self-medication Trend Will Continue To Benefit OTC Healthcare Over 2008-2013
- Key Trends and Developments
- Economic and Political Problems Inhibit OTC Healthcare Performance
- OTC Healthcare Distribution Outside Chemists/pharmacies Is Slow To Take Off
- Algoflex Attempts To Fill the Space Vacated by Algopyrin in Analgesics
- Pharmacy Deregulation Improves OTC Healthcare Distribution
- Hungarians Continue To Live Unhealthy Lifestyles
- Market Indicators
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Market Data
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
- OTC Registration and Classification
- Advertising
- Packaging
- Labelling
- Distribution
- Vitamins & Dietary Supplements Registration and Classification
- EU Legislation
- Self-medication and Preventative Medicine
- Generics
- Switches
Summary 1 OTC Healthcare Switches: 2005-2007 (note: re-switch: the status of drugs was changed formerly from Rx to OTC, and current re-switch changed
- Definitions
Summary 2 Research Sources
- Egis Rt
- Strategic Direction
- Key Facts
Summary 3 Egis Rt: Key Facts
Summary 4 Egis Rt : Operational Indicators 2005-2007
- Company Background
- Production
- Competitive Positioning
Summary 5 Egis Rt: Competitive Position 2008
- Extractum-pharma Rt
- Strategic Direction
- Key Facts
Summary 6 Extractum-Pharma Rt: Key Facts
Summary 7 Extractum-Pharma Rt: Operational Indicators 2005-2007
- Company Background
- Production
- Competitive Positioning
Summary 8 Extractum-Pharma Rt: Competitive Position 2008
- Pannonpharma Kft
- Strategic Direction
- Key Facts
Summary 9 PannonPharma Kft: Key Facts
Summary 10 PannonPharma Kft: Operational Indicators 2005-2007
- Company Background
- Production
- Competitive Positioning
Summary 11 PannonPharma Kft: Competitive Position 2008
- Richter Gedeon Rt
- Strategic Direction
- Key Facts
Summary 12 Richter Gedeon Rt: Key Facts
Summary 13 Richter Gedeon Rt: Operational Indicators 2005-2007
- Company Background
- Production
- Competitive Positioning
Summary 14 Richter Gedeon Rt: Competitive Position 2008
- Teva Magyarorsz??g Rt
- Strategic Direction
- Key Facts
Summary 15 Teva Magyarorsz??g Rt: Key Facts
Summary 16 Teva Magyarorsz??g Rt: Operational Indicators 2005-2007
- Company Background
- Production
- Competitive Positioning
Summary 17 Teva Magyarorsz??g Rt: Competitive Position 2008
- Headlines
- Trends - Vitamins
- Trends - Dietary Supplements
- Competitive Landscape
- Prospects
- Sector Data
- Table 12 Dietary Supplements: Brand Ranking by Positioning 2008
- Table 13 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
- Table 14 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
- Table 15 Folic Acid v Other B Vitamins 2004-2008
- Table 16 Dietary Supplements by Positioning 2006-2008
- Table 17 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
- Table 18 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
- Table 19 Vitamins Brand Shares by Value 2005-2008
- Table 20 Dietary Supplements Brand Shares by Value 2005-2008
- Table 21 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
- Table 22 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013